Vivos Therapeutics, Inc. (VVOS) Insider Trading Disclosures
Vivos Therapeutics, Inc. (VVOS) is a publicly traded company on the Nasdaq, categorized under SIC 3841 (Surgical & Medical Instruments & Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: VVOS
CIK: 1716166
Exchange: Nasdaq
SIC 3841: Surgical & Medical Instruments & Apparatus
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Baker Tilly US, LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerGregory Pfahl
Audit LocationDenver, Colorado, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-15 | 2026-10-14 | 8-K | 0001493152-26-047158 | View SEC Doc Filr Page |
| 8-K | 2026-10-01 | 2026-09-29 | 8-K | 0001493152-26-045193 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-14 | 4 | 0001493152-26-043443 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-14 | 4 | 0001493152-26-043441 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-06-30 | 4 | 0001493152-26-043383 | View SEC Doc Filr Page |
| 8-K/A | 2026-09-08 | 2026-09-02 | 8-K/A | 0001493152-26-041807 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-08-31 | 8-K | 0001493152-26-041616 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-09-03 | — | SCHEDULE 13G/A Filing | 0001851416-26-000030 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-07-31 | 4 | 0001493152-26-040238 | View SEC Doc Filr Page |
| 8-K | 2026-08-21 | 2026-08-20 | 8-K | 0001493152-26-039736 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001493152-26-038336 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003625 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-05 | 8-K | 0001493152-26-037173 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-11 | — | SCHEDULE 13G Filing | 0001851416-26-000026 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-07-31 | 8-K | 0001493152-26-035867 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-07-15 | — | SCHEDULE 13D Filing | 0001104659-26-083931 | View SEC Doc Filr Page |
| 4 | 2026-07-15 | 2026-06-30 | 4 | 0001193125-26-304815 | View SEC Doc Filr Page |
| 3 | 2026-07-15 | 2026-06-30 | 3 | 0001193125-26-304807 | View SEC Doc Filr Page |
| 8-K | 2026-07-07 | 2026-07-07 | 8-K | 0001493152-26-032387 | View SEC Doc Filr Page |
| 8-K | 2026-06-25 | 2026-06-25 | 8-K | 0001493152-26-030190 | View SEC Doc Filr Page |
| 8-K | 2026-06-16 | 2026-06-16 | 8-K | 0001493152-26-028912 | View SEC Doc Filr Page |
| 8-K | 2026-06-16 | 2026-06-15 | 8-K | 0001493152-26-028775 | View SEC Doc Filr Page |
| 8-K | 2026-06-08 | 2026-06-08 | 8-K | 0001493152-26-027641 | View SEC Doc Filr Page |
| 10-Q | 2026-05-20 | 2026-03-31 | 10-Q | 0001493152-26-024650 | View SEC Doc Filr Page |
| NT 10-Q | 2026-05-15 | 2026-03-31 | NT 10-Q | 0001493152-26-023733 | View SEC Doc Filr Page |